Search

everythinglearnresearchcommunity

for

Search:↓

The skin's dermal layer contains true stem cells with diverse functions and interactions that need more research to fully understand.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

Older skin has higher cancer risk due to inflammation and stem cell issues.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Skin has specialized touch receptors that can tell different sensations apart.

Skin organoids are a promising new model for studying human skin development and testing treatments.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Researchers successfully transplanted hair follicles in mice, which survived well and helped in wound healing.

Pantethine may boost the immune system's ability to fight sarcoma.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Loss of TET2 increases the risk of skin and oral cancer.